Pharmacological treatment of stable angina pectoris: the place of trimetazidine
According to international epidemiological studies, the total number of reported cases of cardiovascular diseases (CVD) almost doubled from 1990 to 2019, reaching 523 million and the number of deaths from CVD in 2019 increased by more than 1.5 times (18,6 million). Coronary artery disease (CAD) and...
Saved in:
| Main Author: | E. A. Temnikova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
InterMedservice
2022-12-01
|
| Series: | Евразийский Кардиологический Журнал |
| Subjects: | |
| Online Access: | https://www.heartj.asia/jour/article/view/6352 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
by: Y. V. Gavrilov, et al.
Published: (2015-12-01) -
Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris
by: V. V. Kashtalap, et al.
Published: (2019-11-01) -
Effects of Trimetazidine Combined with Atorvastatin on Cardiac Function in Patients with Stable Angina Pectoris of Coronary Heart Disease
by: Zhang N, et al.
Published: (2025-04-01) -
THE EXPERIENCE OF MOLSIDOMINE USAGE IN PATIENTS WITH STABLE ANGINA PECTORIS
by: I. I. Sinitsina, et al.
Published: (2015-12-01) -
Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study
by: Luís Henrique Wolff Gowdak, et al.
Published: (2025-04-01)